RGNT
Regentis Biomaterials Ltd.
NYSE: RGNT · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$1.37
+0.00% today
Updated 2026-11-03
Market cap
$8.85M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.46
Dividend yield
—
52W range
$1 – $9
Volume
0.0M
WallStSmart proprietary scores
26
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.3
Quality
C+3.5
Profitability
D5.0
Valuation
C+3/9
Piotroski F-Score
Weak
-14.3
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →252 stocks currently score above 75
Price targets
Analyst target
$10.00
+629.93%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
Stock snapshot
Strengths
Insufficient data
Risks
- Piotroski 3/9 — weak financial health
- Altman Z -14.29 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-1.38M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-1.45M | $-4.13M | $4.80M | $-13.65M | $-13.65M |
| EPS | — | — | — | — | $-2.46 |
| Free cash flow | $-1.50M | $-1.22M | $-641000.00 | $-1.38M | $-1.38M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Regentis Biomaterials Ltd. trades at $1.37. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -14.29, it sits in the distress.
Frequently asked questions
What is Regentis Biomaterials Ltd.'s stock price?
Regentis Biomaterials Ltd. (RGNT) trades at $1.37.
Is Regentis Biomaterials Ltd. overvalued?
Regentis Biomaterials Ltd. carries a Smart Value Score of 26/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of Regentis Biomaterials Ltd. (RGNT)?
The 12-month analyst consensus target is $10.00, about 629.9% above the current $1.37. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
Altman Z-Score?
Regentis Biomaterials Ltd.'s Altman Z-Score is -14.29, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryMEDICAL INSTRUMENTS & SUPPLIES
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio—
ROE—
Beta—
50D MA$1.84
200D MA$3.02
Shares out0.01B
Float0.00B
Short ratio—
Avg volume0.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—